Evidence map›Paper›PMID 26994427›Full record

ReviewAtherosclerosis2016

Vascular endothelium - Gatekeeper of vessel health.

Paul A Cahill, Eileen M Redmond

Registry-linked trialAbstract readReview
In one paragraph

Review in Atherosclerosis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06684912 (Acute Effects of Moderate Intensity Continuous Exercise Versus High-Intensity Interval Exercise on Flow Mediated Slowing and Flow Mediated Dilation in Adults With and Without Type 2 Diabetes), which is not on this map. Cited by 263 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
263citing papers in PubMed, 1 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06684912 nacompletednot on this mapstarted 2020, after this paper: background citation

Acute Effects of Moderate Intensity Continuous Exercise Versus High-Intensity Interval Exercise on Flow Mediated Slowing and Flow Mediated Dilation in Adults With and Without Type 2 Diabetes

TypeinterventionalSponsorEgas Moniz - Cooperativa de Ensino Superior, CRLRan2020 to 2022Enrolled36ConditionsDiabetes Mellitus, Type 2ArmsHigh-intensity interval exercise, Moderate continuous exercise
3 · Its place in the literature

Who cites it

263 citing papers in PubMed, 1 synthesis or guideline pooled it, 507 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Nutrients · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Application of PLCL as a biodegradable polymer in biomedical engineering.Journal of materials science. Materials in medicine · 2026
    Review
  18. Article
  19. Article
  20. Article

203 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Paul A CahillVascular Biology and Therapeutics Laboratory, Dublin City University, Dublin, Ireland.
Eileen M RedmondDepartment of Surgery, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: Eileen_Redmond@urmc.rochester.edu.
Dublin City University · IEUniversity of Rochester Medical Center · US

Funding

Alcohol Regulation of Resident Vascular Stem Cells.R21AA023213 · NIAAA · UNIVERSITY OF ROCHESTER · PI REDMOND, EILEEN M. · 2015 to 2016
$403k
NIAAA NIH HHS R21 AA023213
6 · The paper itself

Abstract

The vascular endothelium is an interface between the blood stream and the vessel wall. Changes in this single cell layer of the artery wall are believed of primary importance in the pathogenesis of vascular disease/atherosclerosis. The endothelium responds to humoral, neural and especially hemodynamic stimuli and regulates platelet function, inflammatory responses, vascular smooth muscle cell growth and migration, in addition to modulating vascular tone by synthesizing and releasing vasoactive substances. Compromised endothelial function contributes to the pathogenesis of cardiovascular disease; endothelial 'dysfunction' is associated with risk factors, correlates with disease progression, and predicts cardiovascular events. Therapies for atherosclerosis have been developed, therefore, that are directed towards improving endothelial function.

Indexed as

AnimalsAnti-Inflammatory AgentsAtherosclerosisCardiovascular DiseasesCoronary Artery DiseaseEndothelium, VascularExerciseFibrinolytic AgentsGlycocalyxHemodynamicsHumansInflammationMiceMuscle, Smooth, VascularPermeabilityRisk FactorsAnti-Inflammatory AgentsFibrinolytic AgentsVasoconstrictor AgentsVasodilator AgentsAtherosclerosisCardiovascular diseaseClinical therapiesEndothelial dysfunctionEndotheliumReviewVessel remodeling

Identifiers

PMID26994427
PMCPMC6478391
OpenAlexW2300272821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.